Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
GSK Investigational Site, London, United Kingdom
GSK Investigational Site, Harrow, Middlesex, United Kingdom
GSK Investigational Site, Manchester, United Kingdom
GSK Investigational Site, London, United Kingdom
Allan Churukian, National City, California, United States
Breco Research, Houston, Texas, United States